Literature DB >> 32474538

Hospitalizations for tuberculous peritonitis in the United States: Results from the national inpatient sample database from 2002 to 2014.

Eric Martin Sieloff1, Adam Timothy Ladzinski1, Neiberg de Alcantara Lima1, Duncan Vos2, Harry Boamah3, Thomas Andrew Melgar4.   

Abstract

Background: Tuberculosis (TB) is an uncommon disease in the Western hemisphere that can present with peritoneal involvement, as tuberculous peritonitis(TBP) causing abdominal pain and fever. The healthcare and economic burden of TBP in the United States remains unknown.
Methods: The National Inpatient Sample database was utilized to investigate TBP hospitalizations from 2002 to 2014. Economic expenditures, patient and hospital demographics, and associations of certain comorbidities with TBP were analyzed.
Results: A total of 5878 hospitalizations for TBP occurred over the 12-year duration, with $420 million in-hospital charges. The median patient age was 45 years (interquartile range: 31.1-61.7), with the majority being Hispanic (27.15%). Hospitalizations occurred primarily in the Western (31.3%) and Southern (31.7%) United States. Patient comorbidities and the respective odds ratio associated with TBP included HIV (33.56), continuous peritoneal dialysis (10.49), malnutrition (7.38), liver cirrhosis (6.87), and liver cirrhosis sequelae (6.91). Nearly 6.37% of TBP hospitalizations also had active pulmonary TB.
Conclusion: Although TBP is uncommon in the United States, it should be considered in patients presenting with abdominal pain and fever and a history of HIV, continuous peritoneal dialysis, malnutrition, liver cirrhosis, or liver cirrhosis sequelae.

Entities:  

Keywords:  Epidemiology; United States; peritonitis; risk factors; tuberculosis

Mesh:

Year:  2020        PMID: 32474538     DOI: 10.4103/ijmy.ijmy_68_20

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  2 in total

1.  Acid fast bacillus smear, mycobacterial culture and Xpert MTB/RIF assay for the diagnosis of tuberculous peritonitis in patients with and without end stage renal failure.

Authors:  Richa Misra; Mitra Kar; Samir Mohindra; Amit Gupta
Journal:  Access Microbiol       Date:  2022-08-11

2.  Expression of Adenosine Deaminase and NLRP3 Inflammasome in Tuberculous Peritonitis and Their Relationship with Clinical Efficacy.

Authors:  Hongwei Su; Guorong Yan; Zijian Li; Lin Fu; Lingdi Li
Journal:  Dis Markers       Date:  2022-09-15       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.